Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02VHD
|
|||
| Former ID |
DIB020929
|
|||
| Drug Name |
SCH51866
|
|||
| Synonyms |
SCH 51866; SCH-51866
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H18F3N5O
|
|||
| Canonical SMILES |
CN1C(=O)C2=C(N=C(N2)CC3=CC=C(C=C3)C(F)(F)F)N4C1=NC5C4CCC5
|
|||
| InChI |
1S/C19H18F3N5O/c1-26-17(28)15-16(27-13-4-2-3-12(13)23-18(26)27)25-14(24-15)9-10-5-7-11(8-6-10)19(20,21)22/h5-8,12-13H,2-4,9H2,1H3,(H,24,25)/t12-,13+/m0/s1
|
|||
| InChIKey |
JOSMPBVYYKRYLG-QWHCGFSZSA-N
|
|||
| CAS Number |
CAS 167298-74-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Phosphodiesterase 1A (PDE1A) | Target Info | Inhibitor | [2] |
| Phosphodiesterase 1B (PDE1B) | Target Info | Inhibitor | [2] | |
| Phosphodiesterase 1C (PDE1C) | Target Info | Inhibitor | [2] | |
| Phosphodiesterase 5A (PDE5A) | Target Info | Inhibitor | [2] | |
| Phosphodiesterase 7B (PDE7B) | Target Info | Inhibitor | [3] | |
| Phosphodiesterase 9 (PDE9) | Target Info | Inhibitor | [4] | |
| KEGG Pathway | Purine metabolism | |||
| cGMP-PKG signaling pathway | ||||
| Calcium signaling pathway | ||||
| Morphine addiction | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Pathway Interaction Database | Regulation of Androgen receptor activity | |||
| Reactome | cGMP effects | |||
| G alpha (s) signalling events | ||||
| WikiPathways | G Protein Signaling Pathways | |||
| DAG and IP3 signaling | ||||
| Opioid Signalling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5270). | |||
| REF 2 | Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor. J Cardiovasc Pharmacol. 1996 Dec;28(6):862-9. | |||
| REF 3 | Identification of human PDE7B, a cAMP-specific phosphodiesterase. Biochem Biophys Res Commun. 2000 May 19;271(3):575-83. | |||
| REF 4 | Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem. 1998 Jun 19;273(25):15559-64. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.